Ascendance Biotechnology's Acquisition

Ascendance Biotechnology was acquired by BioIVT on March 27, 2018.

Ascendance Biotechnology is was formed by BioTime and Hepregen Corporation to address the In Vitro cell biology market. Ascendance combines Hepregen's application-directed, cellular micro-patterning d…

Articles about Ascendance Biotechnology's Acquisition: